Northpond Ventures, LP

13D and 13G Filings

Issuer	Symbol	CUSIP	% of Class	Shares	Form	Filed
Mereo BioPharma Group plc 13G/A Amendment 1 MREO · 589492107	MREO	589492107	0%	0	13G/A Amendment 1	2/17/2026 Event 12/31/2025
Northpond Ventures, LP			0%	0
Northpond Ventures GP, LLC			0%	0
Northpond Ventures II, LP			0%	0
Northpond Ventures II GP, LLC			0%	0
NPV Listed, LLC			0%	0
Northpond Ventures, LLC			0%	0
Michael P. Rubin			0%	0
Mereo BioPharma Group plc 13G MREO · 589492107	MREO	589492107	6.9%	54,521,000	13G	6/11/2025 Event 6/4/2025
Northpond Ventures, LP			4.4%	35,223,695
Northpond Ventures GP, LLC			4.4%	35,223,695
Northpond Ventures II, LP			2.1%	16,454,455
Northpond Ventures II GP, LLC			2.1%	16,454,455
NPV Listed, LLC			0.4%	2,842,850
Northpond Ventures, LLC			0.4%	2,842,850
Michael P. Rubin			6.9%	54,521,000
Vigil Neuroscience, Inc. 13D/A Amendment 2 VIGL · 92673K108	VIGL	92673K108	0%	0	13D/A Amendment 2	5/27/2025 Event 5/22/2025
Northpond Ventures, LP			0%	0
Northpond Ventures GP, LLC			0%	0
Northpond Ventures II, LP			0%	0
Northpond Ventures II GP, LLC			0%	0
Michael P. Rubin			0%	0
Candel Therapeutics, Inc. 13G/A Amendment 1 CADL · 137404109	CADL	137404109	0%	0	13G/A Amendment 1	2/14/2025 Event 12/31/2024
Northpond Ventures, LP			0%	0
Northpond Ventures GP, LLC			0%	0
Northpond Ventures II, LP			0%	0
Northpond Ventures II GP, LLC			0%	0
Michael P. Rubin			0%	0

Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.